Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03820297 · ClinicalTrials.gov registry record · NA
Anti-stigma Intervention for Chinese American Older Adults
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03820297 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 16 participants.
The verdict
NCT03820297, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Approximately 50 participants will be enrolled and screened to achieve 45 eligible patients with mood/anxiety disorders to complete a 10 weekly anti-stigma group intervention (ASGI) in addition to several self-report internalized stigma and psychiatric measures.This study will examine changes in internalized stigma and psychiatric symptoms pre- and post-ASGI with 3 months post-intervention follow-up.
Interventions
- BEHAVIORAL 10 sessions of ASGI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03820297
The ClinicalTrials.gov registry entry for NCT03820297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 10 sessions of ASGI is the first listed.
NCT03820297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03820297 about?
NCT03820297 is a clinical study titled "Anti-stigma Intervention for Chinese American Older Adults". Approximately 50 participants will be enrolled and screened to achieve 45 eligible patients with mood/anxiety disorders to complete a 10 weekly anti-stigma group intervention (ASGI) in addition to several self-report internalized stigma and psychiatric measures.This study will examine changes in int...
What is the current status of trial NCT03820297?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-08-19. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03820297?
The interventions under investigation include: 10 sessions of ASGI (BEHAVIORAL).
Who is sponsoring clinical trial NCT03820297?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.